Potential Predictive Value of MiR-125b-5p, MiR-155-5p and Their Target Genes in the Course of COVID-19

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2022 Aug 8

PMID 35937783

Authors

Xuewen Li

Yiting Wang

Qi Zhou

Junqi Pan

Jiancheng Xu

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to provide new biomarkers for predicting the disease course of COVID-19 by analyzing the dynamic changes of microRNA (miRNA) and its target gene expression in the serum of COVID-19 patients at different stages.

Methods: Serum samples were collected from all COVID-19 patients at three time points: the acute stage, the turn-negative stage, and the recovery stage. The expression level of miRNA and the target mRNA was measured by Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR). The classification tree model was established to predict the disease course, and the prediction efficiency of independent variables in the model was analyzed using the receiver operating characteristic (ROC) curve.

Results: The expression of miR-125b-5p and miR-155-5p was significantly up-regulated in the acute stage and gradually decreased in the turn-negative and recovery stages. The expression of the target genes CDH5, STAT3, and TRIM32 gradually down-regulated in the acute, turn-negative, and recovery stages. MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 constituted a classification tree model with 100% accuracy of prediction and AUC >0.7 for identification and prediction in all stages.

Conclusion: MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 could be useful biomarkers to predict the time nodes of the acute, turn-negative, and recovery stages of COVID-19.

Citing Articles

The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis.

Belete M, Anley D, Tsega S, Moges N, Anteneh R, Zemene M BMC Infect Dis. 2024; 24(1):1011.

PMID: 39300343 PMC: 11414062. DOI: 10.1186/s12879-024-09915-8.

Bioinformatics and system biology approach to identify potential common pathogenesis for COVID-19 infection and sarcopenia.

Zhong J, Yuan H, Yang J, Du Y, Li Z, Liu X Front Med (Lausanne). 2024; 11:1378846.

PMID: 38978778 PMC: 11228343. DOI: 10.3389/fmed.2024.1378846.

COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments.

Gilyazova I, Timasheva Y, Karunas A, Kazantseva A, Sufianov A, Mashkin A Noncoding RNA Res. 2023; 8(2):240-254.

PMID: 36852336 PMC: 9946734. DOI: 10.1016/j.ncrna.2023.02.007.

References

Visacri M, Nicoletti A, Pincinato E, Loren P, Saavedra N, Saavedra K . Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field. Biomark Med. 2021; 15(18):1785-1795. PMC: 8601154. DOI: 10.2217/bmm-2021-0348. View

Garcia-Hidalgo M, Gonzalez J, Benitez I, Carmona P, Santisteve S, Perez-Pons M . Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS. Emerg Microbes Infect. 2022; 11(1):1537-1549. PMC: 9176679. DOI: 10.1080/22221751.2022.2081615. View

Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y . Kidney Biopsy Findings in Patients with COVID-19. J Am Soc Nephrol. 2020; 31(9):1959-1968. PMC: 7461665. DOI: 10.1681/ASN.2020060802. View

Bonilla-Muro M, Hernandez de la Cruz O, Gonzalez-Barrios J, Alcaraz-Estrada S, Castanon-Arreola M . EsxA mainly contributes to the miR-155 overexpression in human monocyte-derived macrophages and potentially affect the immune mechanism of macrophages through miRNA dysregulation. J Microbiol Immunol Infect. 2019; 54(2):185-192. DOI: 10.1016/j.jmii.2019.07.007. View

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

Muller M, Hubner M, Li L, Tomasi S, Liesske V, Effinger D . Cell-Crossing Functional Network Driven by microRNA-125a Regulates Endothelial Permeability and Monocyte Trafficking in Acute Inflammation. Front Immunol. 2022; 13:826047. PMC: 8986987. DOI: 10.3389/fimmu.2022.826047. View

Chu M, Fan Y, Wu L, Ma X, Sao J, Yao Y . Knockdown of lncRNA BDNF-AS inhibited the progression of multiple myeloma by targeting the miR-125a/b-5p-BCL2 axis. Immun Ageing. 2022; 19(1):3. PMC: 8722203. DOI: 10.1186/s12979-021-00258-5. View

Farr R, Rootes C, Stenos J, Foo C, Cowled C, Stewart C . Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract. PLoS One. 2022; 17(4):e0265670. PMC: 8982876. DOI: 10.1371/journal.pone.0265670. View

Keikha R, Hashemi-Shahri S, Jebali A . The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur J Med Res. 2021; 26(1):75. PMC: 8276226. DOI: 10.1186/s40001-021-00544-4. View

10.

Kar P, Saleh-E-In M, Jaishee N, Anandraj A, Kormuth E, Vellingiri B . Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19. J Cell Biochem. 2022; 123(5):964-986. DOI: 10.1002/jcb.30243. View

11.

Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J . Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020; 81(1):e28-e32. PMC: 7195339. DOI: 10.1016/j.jinf.2020.03.051. View

12.

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

13.

de Gonzalo-Calvo D, Cenarro A, Garlaschelli K, Pellegatta F, Vilades D, Nasarre L . Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease. J Mol Cell Cardiol. 2017; 106:55-67. DOI: 10.1016/j.yjmcc.2017.03.005. View

14.

Koranteng R, Swindle E, Davis B, Dearman R, Kimber I, Flanagan B . Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin Exp Immunol. 2004; 137(1):81-7. PMC: 1809098. DOI: 10.1111/j.1365-2249.2004.02510.x. View

15.

Sacco G, Foucault G, Briere O, Annweiler C . COVID-19 in seniors: Findings and lessons from mass screening in a nursing home. Maturitas. 2020; 141:46-52. PMC: 7319654. DOI: 10.1016/j.maturitas.2020.06.023. View

16.

Nguyen H, Noss E, Mizoguchi F, Huppertz C, Wei K, Watts G . Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators. Immunity. 2017; 46(2):220-232. PMC: 5567864. DOI: 10.1016/j.immuni.2017.01.004. View

17.

Shi J, Chen X, Yang Q, Wang C, Huang Q, Shen Y . A simple prediction model of hyperuricemia for use in a rural setting. Sci Rep. 2021; 11(1):23300. PMC: 8639845. DOI: 10.1038/s41598-021-02716-y. View

18.

Zhao Y, Lang Y, Zhang M, Liang S, Zhu X, Liu Z . miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury. Kidney Dis (Basel). 2022; 8(2):137-147. PMC: 9021629. DOI: 10.1159/000520140. View

19.

Wang Y, Zhu X, Jiang X, Guo J, Fu Z, Zhou Z . Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduct Target Ther. 2021; 6(1):300. PMC: 8355568. DOI: 10.1038/s41392-021-00716-y. View

20.

Iravani Saadi M, Ramzi M, Hesami Z, Kheradmand N, Owjfard M, Nabi Abdolyousefi E . MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses. Virusdisease. 2021; 32(4):727-736. PMC: 8543773. DOI: 10.1007/s13337-021-00743-x. View